UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 79 filers reported holding UTAH MED PRODS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q2 2022$3,780,000440.00%
Other shareholders
UTAH MED PRODS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Clean Yield Group 26,010$2,305,0001.00%
Ranger Investment Management 67,256$5,960,0000.41%
Hayden Royal, LLC 11,709$660,739,0000.37%
AFFINITY INVESTMENT ADVISORS, LLC 7,331$650,0000.31%
ISTHMUS PARTNERS, LLC 13,561$1,202,0000.30%
RICE HALL JAMES & ASSOCIATES, LLC 72,284$6,406,0000.28%
Cardinal Capital Management 9,272$821,0000.24%
Ancora Advisors LLC 52,873$4,686,0000.20%
GLOBEFLEX CAPITAL L P 5,605$497,0000.13%
Penobscot Investment Management Company, Inc. 4,000$354,0000.07%
View complete list of UTAH MED PRODS INC shareholders